Utilization of patient-reported outcomes to assess adherence to relugolix when combined with stereotactic body radiation therapy for intermediate to high-risk prostate cancer

Utilization of patient-reported outcomes to assess adherence to relugolix when combined with stereotactic body radiation therapy for intermediate to high-risk prostate cancer

IntroductionInjectable GnRH receptor agonists have been shown to improve cancer control when combined with radiotherapy (RT). Relugolix is an oral GnRH receptor antagonist that achieves rapid testosterone suppression. Non-adherence to oral medications due to poor social support or bothersome side ef...

Full description

Saved in:
Bibliographic Details
Main Authors: Kelly Gaudian, Min Jung Koh, Min Ji Koh, Ryan R. Collins, Shaine Eden, Zoya Zwart, Malika Danner, Alan Zwart, Mark Fallick, Deepak Kumar, Paul Leger, Nancy A. Dawson, Simeng Suy, Sean P. Collins
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Oncology
Subjects:
SBRT (stereotactic body radiation therapy)
relugolix
ADT (androgen deprivation therapy)
prostate cancer
medication adherence
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1540482/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items